Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach

Background. Mitogen-activated protein kinase 3 (MAPK3) mediates the onset, progression, metastasis, drug resistance, and poor prognosis in various malignancies, including glioma, liver, ovarian, thyroid, lung, breast, gastric, and oral cancers. Negative regulation of MAPK3 expression using miRNAs ha...

Full description

Bibliographic Details
Main Authors: Amir Taherkhani, Parita Khodadadi, Lida Samie, Zahra Azadian, Zeynab Bayat
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:International Journal of Analytical Chemistry
Online Access:http://dx.doi.org/10.1155/2023/8899240